The Hanover Insurance Group, Inc.
The Hanover Insurance Group, Inc. (THG) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · THG · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
23
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
The Hanover Insurance Group, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
THG insider buying and selling by quarter
THG insider selling · THG insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · THG ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
THG executive sell shares · THG board member insider trading · THG insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 3, 2026 | Salvatore Bryan J EVP | Option | 16,394 | $1.71M⚡ | Form 4 |
| Jun 3, 2026 | Salvatore Bryan J EVP | Sale | 16,394 | $3.05M⚡ | Form 4 |
| May 21, 2026 | Aristeguieta Francisco Director | Sale | 1,000 | $195K | Form 4 |
| May 19, 2026 | Roche John C President and CEO · Director | Option | 24,026 | $2.50M⚡ | Form 4 |
| May 19, 2026 | Roche John C President and CEO · Director | Option | 9,098 | $781K | Form 4 |
| May 19, 2026 | Roche John C President and CEO · Director | Other | 24,766 | $4.80M⚡ | Form 4 |
| May 20, 2026 | Roche John C President and CEO · Director | Sale | 3,152 | $609K | Form 4 |
| May 20, 2026 | Roche John C President and CEO · Director | Sale | 5,145 | $998K | Form 4 |
| May 20, 2026 | Roche John C President and CEO · Director | Sale | 61 | $12K | Form 4 |
| May 20, 2026 | Kerrigan Dennis Francis EVP | Option | 6,262 | $722K | Form 4 |
| May 20, 2026 | Kerrigan Dennis Francis EVP | Sale | 6,262 | $1.21M⚡ | Form 4 |
| May 15, 2026 | Roche John C President and CEO · Director | Option | 18,194 | $1.56M⚡ | Form 4 |
| May 15, 2026 | Roche John C President and CEO · Director | Other | 12,943 | $2.52M⚡ | Form 4 |
| May 18, 2026 | Roche John C President and CEO · Director | Sale | 375 | $74K | Form 4 |
| May 18, 2026 | Roche John C President and CEO · Director | Sale | 2,260 | $447K | Form 4 |
| May 18, 2026 | Roche John C President and CEO · Director | Sale | 2,516 | $500K | Form 4 |
| May 18, 2026 | Roche John C President and CEO · Director | Sale | 100 | $20K | Form 4 |
| May 14, 2026 | Lowsley Denise EVP | Option | 4,175 | $482K | Form 4 |
| May 14, 2026 | Lowsley Denise EVP | Sale | 4,175 | $800K | Form 4 |
| May 12, 2026 | Donnell William E. Director | Award | 843 | — | Form 4 |
| May 12, 2026 | Ward Elizabeth A Director | Award | 843 | — | Form 4 |
| May 12, 2026 | LANE KATHY S Director | Award | 843 | — | Form 4 |
| May 12, 2026 | RAMRATH JOSEPH R Director | Award | 843 | — | Form 4 |
| May 12, 2026 | Condrin J Paul Director | Award | 843 | — | Form 4 |
| May 12, 2026 | Bunting Theodore H JR Director | Award | 843 | — | Form 4 |
Roche John C
President and CEO · Director
Date
May 19
Shares
24,026
Price
$104.11
Value
$2.50M ⚡
Roche John C
President and CEO · Director
Date
May 19
Shares
9,098
Price
$85.87
Value
$781K
Roche John C
President and CEO · Director
Date
May 19
Shares
24,766
Price
$193.79
Value
$4.80M ⚡
Roche John C
President and CEO · Director
Date
May 20
Shares
3,152
Price
$193.21
Value
$609K
Roche John C
President and CEO · Director
Date
May 20
Shares
5,145
Price
$194.05
Value
$998K
Roche John C
President and CEO · Director
Date
May 20
Shares
61
Price
$194.77
Value
$12K
Roche John C
President and CEO · Director
Date
May 15
Shares
18,194
Price
$85.87
Value
$1.56M ⚡
Roche John C
President and CEO · Director
Date
May 15
Shares
12,943
Price
$194.64
Value
$2.52M ⚡
Roche John C
President and CEO · Director
Date
May 18
Shares
375
Price
$196.55
Value
$74K
Roche John C
President and CEO · Director
Date
May 18
Shares
2,260
Price
$197.61
Value
$447K
Roche John C
President and CEO · Director
Date
May 18
Shares
2,516
Price
$198.65
Value
$500K
Roche John C
President and CEO · Director
Date
May 18
Shares
100
Price
$199.23
Value
$20K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About THG insider trading
THG insider trades
The Hanover Insurance Group, Inc. (THG) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Roche John C (President and CEO · Director), LAVEY RICHARD W (EVP), Lowsley Denise (EVP). Over the past 12 months, 5 insiders have filed transactions with the SEC. THG insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For The Hanover Insurance Group, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
THG insider trading · 5 questionsThe insiders of The Hanover Insurance Group, Inc. (THG) include executives and directors such as Roche John C (President and CEO · Director), LAVEY RICHARD W (EVP), Lowsley Denise (EVP), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026